Leverkusen

                   

Bayer MaterialScience Polyurethane Composite Provide Eco-Friendly Alternative for Rail Track Support

azom.com     yesterday   1 related          

In Europe, wood or concrete has traditionally been the material of choice for manufacturing the ties or sleepers that are used to support railroad tracks. Now, especially as a replacement for the wooden ties that are generally...                    

comments

                   

Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over...

ad-hoc-news.de     Aug 19, 2008   12 related          

Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular DegenerationTARRYTOWN, N.Y. ;amp; LEVERKUSEN, GermanyNY-REGENERON                    

comments

LANXESS to move Group headquarters to Cologne

moneycontrol.com     Aug 14, 2008   1 related          

Specialty Chemicals Company LANXESS AG plans to move its headquarters from Leverkusen to Cologne. Relocation is to be completed by 2011. LANXESS will now begin discussions with the city of Cologne to identify possible sites.                    

comments

                   

Bayer Technology Services And Xytel Market Microreaction Technology

bioresearchonline.com     Aug 1, 2008   2 related          

Ehrfeld Mikrotechnik BTS GmbH (EMB), a subsidiary of Bayer Technology Services, and Xytel Incorporated have signed a production and marketing agreement to introduce innovative microreaction technology in pilot plants for the...                    

comments

Practical relevance online for every customer

webwire.com     Jul 31, 2008          

New Internet site for thermoplastic polyurethanes: - - Leverkusen, July 2008 — Users of thermoplastic polyurethanes from Bayer MaterialScience have something to look forward to, because starting right ... [WebWire - Thursday,...                    

comments

Bayer 2Q net profit slips 13 percent

iht.com     Jul 30, 2008   19 related          

Chemical and pharmaceutical maker Bayer AG said Wednesday its second quarter net profit fell because of one-time gains last year but raised its sales outlook for this year. The Leverkusen-based maker of the contraceptive...                    

comments

Bayer beantragt US-Zulassung für Rivaroxaban

wallstreet-online.de     Jul 30, 2008          

Leverkusen (aktiencheck.de AG) - Die Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), der Kooperationspartner der Bayer AG (ISIN DE0005752000/ WKN 575200) für das Thrombosemittel Rivaroxaban (Xarelto),...                    

comments

                   

Bayer's Novel Anticoagulant Rivaroxaban Recommended for Approval in the EU

webwire.com     Jul 28, 2008   14 related          

Final approval from the European Commission expected within the next few months. - Leverkusen. — The European Committee for Medicinal Products for Human Use (CHMP) has recommended approval of the antic... [WebWire - Monday,...                    

comments

25.07.08: Bayer welcomes the proposed EMEA labeling changes for moxifloxacin which are consistent...

bayer.com     Jul 25, 2008   11 related          

Leverkusen, July 25, 2008 - Bayer is pleased to announce that today the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) proposed a labeling change for oral moxifloxacin for the treatment...                    

comments

                   

25.07.08: Venous Blood Clot Prevention after Elective Hip or Knee Replacement Surgery:

bayer.com     Jul 25, 2008   2 related          

Bayer's Novel Anticoagulant Rivaroxaban Recommended for Approval in the EU Final approval from the European Commission expected within the next few months Leverkusen, July 25, 2008 - The European Committee for Medicinal...                    

comments

1 2 3 4 5 next »